Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 12/31/2025

Laboratory Tests for Lymphadenopathy Evaluation

Initial Laboratory Evaluation

  • The National Comprehensive Cancer Network recommends a complete blood count (CBC) with differential to evaluate for cytopenias, abnormal cell populations, lymphocytosis, or eosinophilia in patients presenting with lymphadenopathy 1, 2
  • A peripheral blood smear review is suggested to identify abnormal cells suggestive of hematologic malignancy, as recommended by the National Comprehensive Cancer Network 2, 3
  • The American College of Clinical Oncology suggests a comprehensive metabolic panel including liver and renal function tests for patients with lymphadenopathy 1, 2
  • Lactate dehydrogenase (LDH) is recommended as a marker for hemolysis or malignancy by the American Society of Clinical Oncology 4, 5

Infectious Disease Workup

  • The Infectious Diseases Society of America recommends bacterial cultures if infection is suspected, particularly for cervical lymphadenopathy 1, 6
  • Viral studies including EBV, CMV, HIV, and hepatitis testing are suggested when clinically indicated by the National Comprehensive Cancer Network 2, 3
  • The Centers for Disease Control and Prevention recommend tuberculosis testing (PPD or interferon-gamma release assay) when granulomatous disease is suspected 6

Additional Testing Based on Clinical Presentation

  • The International Myeloma Society recommends serum protein electrophoresis and immunofixation if paraproteinemia is suspected 3, 5
  • The American Society of Hematology suggests a direct antiglobulin test (DAT) and haptoglobin if hemolysis is suspected 1, 4
  • The Endocrine Society recommends thyroid function tests if thyroid dysfunction is suspected 5
  • The National Comprehensive Cancer Network suggests flow cytometry of peripheral blood for immunophenotyping if lymphoproliferative disorder is suspected 2, 3

Imaging Studies

  • The National Comprehensive Cancer Network recommends a CT scan of the chest, abdomen, and pelvis with contrast to document organomegaly and/or extent of lymphadenopathy 2, 7
  • The American College of Radiology suggests an ultrasound for initial evaluation of superficial lymphadenopathy 3
  • The Society of Nuclear Medicine and Molecular Imaging recommends a PET/CT if transformation to aggressive lymphoma is suspected 2, 8

Advanced Testing When Indicated

  • The National Comprehensive Cancer Network recommends bone marrow aspiration and biopsy with immunohistochemistry if abnormal cells are found in peripheral blood or if myeloproliferative/lymphoproliferative disorder is suspected 2, 3
  • The American Society of Clinical Oncology suggests molecular testing for MYD88 mutation in cases of suspected Waldenström macroglobulinemia 2

Common Pitfalls to Avoid

  • The National Comprehensive Cancer Network recommends avoiding delaying bone marrow evaluation in patients with concerning peripheral blood findings 3
  • The Infectious Diseases Society of America suggests overlooking the need for HIV testing in patients with unexplained lymphadenopathy 1, 6

Laboratory Evaluation and Diagnostic Guidelines for Abnormal Lymphadenopathy

Baseline Laboratory Assessment

Prognostic Biomarkers

Immunophenotyping and Infectious Screening

Tissue Diagnosis Recommendations